Acrux LimitedASX: ACR

Webinar, Monday 12 October 2026 - Female Testosterone MDTS

Oct 8, 2026 at 5:51 PM EDT · Issued by Acrux Limited via ASX

Filed with ASX · Oct 8, 2026 at 5:51 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/webinar-monday-12-october-2026-female-testosterone-mdts

Release

Acrux Limited (ACR:ASX) | ACN 082 001 152 103-113 Stanley St, West Melbourne VIC, 3003 Australia +61 3 8379 0100 | [email protected] Acrux Limited (ACR:ASX) ASX Announcement 9 October 2026 Investor webinar: Female Testosterone MDTS and recent FDA feedback Melbourne, Australia; 9...

Acrux Limited on 6ix

Earlier from Acrux

Acrux has received $1.977m RDTI rebate for FY26Oct 1
Application for quotation of securities - ACRSep 23
AGM date, closing date for director nominationsSep 13
Appendix 3Y BrookeSep 13
Appendix 3Y WarmbrunnSep 2

Later from Acrux

FDA clears regulatory pathway for Female Testosterone MDTSOct 11
Quarterly Activities/Appendix 4C Cash Flow ReportOct 18
Notice of Annual General Meeting/Proxy FormOct 22
Notification of cessation of securities - ACRNov 3

All Acrux news releases

Follow Acrux into a list and get an email when it puts out news.

Follow Acrux